MedTrace Logo

The Experience of Screening for SCID

NCT05651113 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-12-14

No results posted yet for this study

Summary

This project will evaluate the impact of including Severe Combined Immunodeficiency into the newborn bloodspot screening panel. It will recruit parents and health professionals primarily from the sites where this new form of screening is being trialled well as additional sites where clinicians will be involved in the care of these babies and comparator groups are needed.

The proposed work will consist of two work packages. The first, a mixed-methods study conducted with families from the point of screening information being returned through to the child's fifth birthday. The second, a qualitative interview study conducted with health professionals during the clinical evaluation phase of the national pilot programme.

Conditions

  • Severe Combined Immunodeficiency

Interventions

OTHER

SCID Screening

The addition of newborn bloodspot screening for severe combined immunodeficiency

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • University of Sheffield

    collaborator OTHER

  • Coventry University

    collaborator OTHER

  • National Health Service, United Kingdom

    collaborator OTHER_GOV

  • King's College London

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-09
Primary Completion
2029-03-31
Completion
2029-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05651113 on ClinicalTrials.gov